Recent Patents on Anti-Cancer Drug Discovery publishes review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.
Time and Venue: Feb 6th-9th, 2019. Verona, Italy.
About: the 40th EORTC-PAMM Winter meeting is organized by Pharmacology & Molecular Mechanisms Group of the EORTC and will be held from Feb 6th to Feb 9th in Verona Italy. The meeting is preceded by an Educational course organized by our editorial board members Paola Perego and Frits Peters, focusing on preclinical and early-phase clinical pharmacology. The program itself focuses on the role of Drug Metabolism and Pharmacology in resistance to current and new therapeutics in various types of cancer. There will be specific emphasis on the tumor microenvironment, pharmacology of monoclonal antibodies, biosimilars, miRNAs and various OMICs approaches. The meeting is a must-be for translational research and traditionally offers many opportunities for young scientists to present data and develop collaborations.